drugset / Trial / NCT01445964

Effect of SLCO2B1 Genotype and Apple Juice on Pharmacokinetics of Atenolol After Oral Administration in Healthy Male Korean

NCT01445964

Phase 4 Completed 12 enrolled Seoul National University Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

An open-label, single-dose, three-treatment, three-period study to investigate the effect of SLCO2B1 genotype and apple juice on pharmacokinetics of atenolol after oral administration in healthy male Korean.

Timeline

Start
2011-05
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atenolol Other / unclassified Oral

Indications

No indication recorded.